PUMD — ProUroCare Medical Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for ProUroCare Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.75 | 4.37 | 3.29 | 1.94 | 2.71 |
Operating Profit | -2.75 | -4.37 | -3.29 | -1.94 | -2.71 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.58 | -0.682 | -0.357 | -0.103 | -0.129 |
Dividends per Share |